Expertise
2018 in Review: Impactful Literature on Pain & Opioids  |  December 19, 2018

At axialHealthcare, our pain and opioid care solutions are based in and continually updated with the latest peer-reviewed evidence. In order to maintain the highest standards for our products, and the patient care they support, our experts sort through thousands of publications each year. Adding more than 100 publications to our compendium this year, we’ve…

Read More ›
Medical Cannabis: Therapeutic Utility and Risks  |  December 3, 2018

By Louis J Czaja, PharmD, BCGP, Clinical Pharmacy Specialist As America’s opioid epidemic continues to escalate, the discussion surrounding legalizing medical marijuana has been widely considered as a means to combat it. Currently, marijuana is the most commonly used illicit drug in the United States, with 40 million people 12 years of age or older reporting…

Read More ›
axial takeaway: “It’s not just biology”  |  November 20, 2018

By Amber Watson, PharmD, Clinical Pharmacist, Scientific Writer The World Health Organization defines social determinants of health (SDOH) as “the conditions in which people are born, grow, live, work, and age.” Examples of SDOH include economic stability, education, and social support. As the health system moves away from fee-for-service reimbursement and toward value-based care reimbursement,…

Read More ›
Recent Opioid Legislation: What it means for payers  |  June 28, 2018

For the past 18 months, the Trump Administration and Congress have been working feverishly to continue the fight against the nation’s opioid epidemic, and the House has spent the last several weeks discussing more than 50 bills, all of which focus on advancing treatment and recovery initiatives, improving prevention, protecting communities, and bolstering efforts to…

Read More ›
Opioid, Pain & Chronic: How 3 Words Can Impact Our Solutions  |  December 21, 2017

In order to successfully offer clinicians and patients the highest quality pain care resources and tools, our solutions need to be informed by the latest evidence-based research. To do this, our data science and analytics team curates an extensive library of relevant literature, which is then used to define our methodology and inform capabilities like…

Read More ›
Substance Use Disorder and the Holidays  |  December 8, 2017

Although it should be a time of joy, many families will face tough situations this holiday season on account of a devastating drug epidemic. According to the Centers for Disease Control and Prevention (CDC), drug overdoses killed approximately 64,000 people in the US last year, rising more than 22% compared to 2015’s 52,404 recorded drug deaths….

Read More ›